M&A Deal Summary

OncoDNA Acquires IntegraGen

On August 12, 2020, OncoDNA acquired healthcare services company IntegraGen for 15M EUR

Acquisition Highlights
  • This is OncoDNA’s 1st transaction in the Healthcare Services sector.
  • This is OncoDNA’s largest (disclosed) transaction.
  • This is OncoDNA’s 1st transaction in France.

M&A Deal Summary
Date 2020-08-12
Target IntegraGen
Sector Healthcare Services
Buyer(s) OncoDNA
Deal Type Add-on Acquisition
Deal Value 15M EUR

Target

IntegraGen

Evry, France
IntegraGen is a company specializing in precision medicine for the treatment of cancer and other genetic diseases. IntegraGen is based in Evry, France.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

OncoDNA

Gosselies, Belgium
Category Company
Founded 2012
Sector Life Science
DESCRIPTION

OncoDNA is an oncology-focused healthcare technology company that combines advanced, comprehensive testing of all clinically relevant cancer biomarkers (DNA, RNA and protein profiles) from both solid and liquid biopsies with a proprietary cancer treatment knowledge database called OncoKDO™ which continuously ‘learns’ from cutting-edge, validated, scientific and medical advances. OncoDNA was founded in 2012 and is based in Gosselies, Belgium.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (France) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal